🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

RecruitingNAAges 25 Years - 65 YearsAllCentre Hospitalier Intercommunal Creteil
NCT06527456 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Woman aged 25 to 65 living in Ile-De-France * Eligible for DOCCU (not hysterectomized, not followed for a pre-cancerous or cancerous lesion of the cervix) * Having declared the investigating general practitioner as a treating physician (MT) and whose MT practices in the territory of a CPTS in the UPEC area * Affiliate to a social security scheme or beneficiary of such a scheme Exclusion Criteria: * Patient already included in a study on DOCCU * Patient excluded from organized screening (cervical cancer, hysterectomy). * Patient's opposition to participating in the study
💊

What it tests

  • participation of the general practitioner
📍

Where

1 site
Médecins généralistes dans le bassin de l'UPEC
Créteil, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy